Kidney Res Clin Pract.
2018 Dec;37(4):426-426. 10.23876/j.krcp.2018.37.3.248.corr.
Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy [Volume 37, Issue 3, September 2018, Pages 248–256]
- Affiliations
-
- 1Department of Internal Medicine, Daehyun Chumdan Geriatric Hospital, Daegu, Korea.
- 2Division of Nephrology and Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea. sh-park@knu.ac.kr
- KMID: 2447192
- DOI: http://doi.org/10.23876/j.krcp.2018.37.3.248.corr
Abstract
- In the article, there was an error in Figure 3.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy
- Anti-phospholipase A2 receptor antibodies in membranous nephropathy
- The optimal anti-phospholipase A2 receptor cutoff for the diagnosis of idiopathic membranous nephropathy: a single-center retrospective study
- Expression of Phospholipase A2 Receptor in PediatricHepatitis B Virus-Related Membranous Nephropathy
- A Case of ANA-negative, Anti-dsDNA Negative, and Anti-Ro/SSA Positive Membranous Lupus Nephropathy
